HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

A selection of health policy stories from Minnesota, Texas, Louisiana, Florida, New York and Massachusetts.

24 Feb 2014

Social/behavioral intervention strategies may help drug users avoid injection-related HCV, HIV infections

Despite a number of social/behavioral intervention and educational programs, the spread of hepatitis C (HCV) in people who inject drugs (PWIDs) remains a chronic problem.

24 Feb 2014

First Edition: February 21, 2014

Today's headlines include reports checking the status of different state health exchanges as well as efforts to expand Medicaid.

21 Feb 2014

Beta version of Cover Oregon gets mixed reviews

The troubled Cover Oregon insurance exchange unveiled its long-awaited beta website to mixed reviews Tuesday. Meanwhile, Humana announced it will waive fees for enrollees who bought plans on the Mississippi exchange who see a doctor by the end of June for a non-preventive visit. Also, Republicans probe state websites which are still having major problems.

19 Feb 2014

Researchers reveal effectiveness of web-based weight-loss programs

Researchers from The Miriam Hospital have found that DietBet, a web-based commercial weight loss program that pairs financial incentives with social influence, delivers significant weight losses. The study and its findings have been published in the current issue of the open access publication JMIR Serious Games.

19 Feb 2014

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).

19 Feb 2014

The obese, people with AIDS encounter coverage gaps

Many plans sold through the health law's marketplaces don't cover weight loss surgery, and none in Louisiana are accepting payments from a federal program intended to help people with HIV/AIDS. The New York Times explores who benefits from the latest employer mandate extension, and Kaiser Health News answers a question about the health law's impact on a person covered by COBRA.

17 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

People receiving mental health care are up to four times more likely to be infected with HIV than the general population, according to a new study published Feb. 13 in the American Journal of Public Health from researchers at Penn Medicine and other institutions who tested over 1,000 patients in care in Philadelphia and Baltimore.

14 Feb 2014

South African pediatrician receives 2013 Scientific Freedom and Responsibility Award from AAAS

Hoosen Coovadia, a South African pediatrician and research scientist, and international authority on HIV/AIDS, particularly mother-to-child transmission, has been named recipient of the 2013 Scientific Freedom and Responsibility Award from the American Association for the Advancement of Science.

13 Feb 2014

Tamoxifen drug appears to kill fungus associated with deadly brain infection

The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a University of Rochester study published online today by mBio, the journal of the American Society for Microbiology.

11 Feb 2014

Health people engages in 2 new initiatives to bring down overall women's HIV/AIDS infection rate

With the Bronx still having the highest rate of new women's HIV/AIDS cases of any New York City borough, Health People: Community Preventive Health Institute is engaged in two important new initiatives to provide prevention and services to women in greatest need. Both offer great potential to develop better strategies to assure the Bronx brings down its overall women's HIV/AIDS infection rate.

11 Feb 2014

Dental care in schools for children wipes out social inequities

A new survey conducted by the University of Copenhagen and the World Health Organization (WHO) is highlighting the role of schools in work to promote health and prevent disease.

11 Feb 2014

Drug used for treating breast cancer also kills fungal disease

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio-, the online open-access journal of the American Society for Microbiology (ASM.)

11 Feb 2014

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

A screening program for abdominal aortic aneurysms, integrated into an electronic health record, dramatically reduced the number of unscreened at-risk men by more than 50 percent within 15 months, according to a Kaiser Permanente study published today in the Journal of Vascular Surgery. An abdominal aortic aneurysm is a balloon-like bulge in the aorta, which - if ruptured - can result in death.

10 Feb 2014

Obamacare tweaks continue amid complaints

The government will allow consumers who experience life changes, such as a marriage or the birth of a child, to update their plan choices, the administration said. It is also looking at requiring insurers to accept third-party payments, such as those made under the Ryan White CARE Act, to help people with HIV/AIDS pay for expensive drugs. Meanwhile, The Washington Post examines the history of Accenture, the contractor hired to fix healthcare.gov, and finds troubled projects and allegations of ethical lapses.

10 Feb 2014

First Edition: February 10, 2014

Today's headlines include stories about the health law's coverage gap.

10 Feb 2014

Study identifies seven new genetic regions associated with type 2 diabetes

Seven new genetic regions associated with type 2 diabetes have been identified in the largest study to date of the genetic basis of the disease.

9 Feb 2014

Hot flashes, depression and anxiety affect thinking skills of midlife women with HIV

Hot flashes, depression, and most of all, anxiety, affect the thinking skills of midlife women with HIV, so screening for and treating their anxiety may be especially important in helping them function, according to a study just published online in Menopause, the journal of The North American Menopause Society (NAMS).

9 Feb 2014

Penn Medicine launches program to improve health of LGBT individuals

Penn Medicine is the first academic medical center in Philadelphia - one among just a handful of academic medical centers in the U.S.—to launch a program across multiple professional schools and affiliated hospitals at Penn to improve the health of lesbian, gay, bisexual, and transgender (LGBT) individuals.

9 Feb 2014

HIV/AIDS News and Research

Further Reading

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

Social/behavioral intervention strategies may help drug users avoid injection-related HCV, HIV infections

First Edition: February 21, 2014

Beta version of Cover Oregon gets mixed reviews

Researchers reveal effectiveness of web-based weight-loss programs

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

The obese, people with AIDS encounter coverage gaps

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

South African pediatrician receives 2013 Scientific Freedom and Responsibility Award from AAAS

Tamoxifen drug appears to kill fungus associated with deadly brain infection

Health people engages in 2 new initiatives to bring down overall women's HIV/AIDS infection rate

Dental care in schools for children wipes out social inequities

Drug used for treating breast cancer also kills fungal disease

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

Obamacare tweaks continue amid complaints

First Edition: February 10, 2014

Study identifies seven new genetic regions associated with type 2 diabetes

Hot flashes, depression and anxiety affect thinking skills of midlife women with HIV

Penn Medicine launches program to improve health of LGBT individuals

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News